PBH

Prestige Consumer Healthcare Stock Analysis

AI Rating

Fair
  • Quality8/10
  • Growth↓ 1/10
  • Momentum↓ 4/10
Prestige Consumer Healthcare sales and earnings growth
PBH Growth
Low
  • Revenue Y/Y↓ -1.31%
  • EPS Y/Y↓ -11.60%
  • FCF Y/Y↑ 7.44%
Prestige Consumer Healthcare gross and profit margin trends
PBH Profitability
Good
  • Gross margin ↑ 56.10%
  • EPS margin↑ 16.90%
  • ROIC↑ 21.60%
Prestige Consumer Healthcare net debt vs free cash flow
PBH Risk
Great
  • Debt / Equity↓ 0.6
  • Debt / FCF↓ 3.8
  • Interest coverage↑ 7.4

Prestige Consumer Healthcare stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

More Drug Manufacturers - Specialty & Generic stocks ↗